Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- TXG
- Price
- 10.81
- Stock movement down
- -0.06 (-0.55%)
- Company name
- 10X Genomics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Health Information Services
- Market cap
- 1.24B
- Ent value
- 1.05B
- Price/Sales
- 1.96
- Price/Book
- 1.71
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 8.45%
- 1 year return
- -45.90%
- 3 year return
- -33.67%
- 5 year return
- -34.32%
- 10 year return
- -
Last updated: 2025-08-27
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
TXG does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 31.57 |
| Price to FCF | 49.39 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.96 |
| Price to Book | 1.71 |
| EV to Sales | 1.67 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 114.41M |
| EPS (TTM) | -1.51 |
| FCF per share (TTM) | 0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 629.74M |
| Gross profit (TTM) | 414.92M |
| Operating income (TTM) | -178.23M |
| Net income (TTM) | -182.55M |
| EPS (TTM) | -1.51 |
| EPS (1y forward) | -0.17 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 65.89% |
| Operating margin (TTM) | -28.30% |
| Profit margin (TTM) | -28.99% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 398.16M |
| Net receivables | 83.53M |
| Total current assets | 593.89M |
| Goodwill | 4.51M |
| Intangible assets | 16.15M |
| Property, plant and equipment | 442.96M |
| Total assets | 937.79M |
| Accounts payable | 26.21M |
| Short/Current long term debt | 85.88M |
| Total current liabilities | 121.23M |
| Total liabilities | 214.99M |
| Shareholder's equity | 722.80M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 39.17M |
| Capital expenditures (TTM) | 14.13M |
| Free cash flow (TTM) | 25.04M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -25.26% |
| Return on Assets | -19.47% |
| Return on Invested Capital | -24.61% |
| Cash Return on Invested Capital | 3.38% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.02 |
| Daily high | 11.02 |
| Daily low | 10.51 |
| Daily Volume | 3.66M |
| All-time high | 202.37 |
| 1y analyst estimate | 15.08 |
| Beta | 2.03 |
| EPS (TTM) | -1.51 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 27 Oct 2025 |
Downside potential
Loading...
Downside potential data
| TXG | S&P500 | |
| Current price drop from All-time high | -94.66% | -3.04% |
| Highest price drop | -96.47% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -54.21% | -11.04% |
| Avg time to new high | 27 days | 12 days |
| Max time to new high | 1044 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.24B
Marketcap category
Small-cap
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Employees
1306
Website
Investor relations
-
SEC filings
CEO
Serge Saxonov
Country
USA
City
Pleasanton
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page